ReviewOpen access rheumatology : research and reviews2018
Refractory relapsing polychondritis: challenges and solutions.
Review in Open access rheumatology : research and reviews, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Demographic, clinical, treatment, outcome, and comorbidities of patients with relapsing polychondritis: experience from Brazilian tertiary center, and literature review.Advances in rheumatology (London, England) · 2025Review
- IL-17 Inhibitor Secukinumab Achieves Remission in Relapsing Polychondritis: A Case Report.The American journal of case reports · 2025Article
- Relapsing Polychondritis Associated With Thyroid Carcinoma: A First Malagasy Case.Case reports in otolaryngology · 2025Article
- Relapsing polychondritis following PD-1 blockade diagnosed via 18F-FDG PET/CT and improved by steroid administration: a case report and literature review.Frontiers in immunology · 2025Review
- Relapsing Polychondritis: A Case of Marked Improvement After Steroid Administration for Airway Obstruction.Cureus · 2023Article
- Article
- Article
- Co-occurrence of relapsing polychondritis and autoimmune thyroid diseases.Orphanet journal of rare diseases · 2022Article
- Discordance in patient and physician global assessment in relapsing polychondritis.Rheumatology (Oxford, England) · 2022Article
- Eustachian tube involvement in a patient with relapsing polychondritis detected by magnetic resonance imaging: A case report.World journal of clinical cases · 2022Article
- Application of extracorporeal membrane oxygenation to treatment of serious tracheal stenosis caused by relapsing polychondritis: a case report and literature review.The Journal of international medical research · 2021Review
- Bronchoscopy-Guided Intervention Therapy With Extracorporeal Membrane Oxygenation Support for Relapsing Polychondritis With Severe Tracheobronchomalacia: A Case Report and Literature Review.Frontiers in medicine · 2021Article
- Coexistence of Relapsing Polychondritis and Sickle Cell Disease in a Child.Case reports in rheumatology · 2021Article
- [Diagnosis and treatment of laryngotracheal stenosis induced by relapsing polychondritis].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2020Article
- A Rare Cause of Hypopyon Anterior Uveitis: Relapsing Polychondritis.Archives of rheumatology · 2020Article
- Observational study and brief analysis of diagnostic criteria in relapsing polychondritis.Rheumatology international · 2018Observational
- Article
- Audiovestibular Symptoms in Systemic Autoimmune Diseases.Journal of immunology research · 2018Review
- Relapsing Polychondritis-Associated Myocardial Infarction With Non-Obstructive Coronary Arteries.Journal of investigative medicine high impact case reportsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Relapsing polychondritis is a severe systemic immune-mediated disease characterized by an episodic and progressive inflammatory condition with progressive destruction of cartilaginous structures. This disease has for nearly a century kept secrets not yet explained. The real incidence and prevalence of this rare disease are unknown. The multiple clinical presentations and episodic nature of relapsing polychondritis cause a significant diagnosis delay. No guidelines for the management of patients with relapsing polychondritis have been validated to date. The challenges remain, both in the understanding of its pathophysiology and diagnosis, evaluation of its activity and prognosis, and its treatment. Possible solutions involve the sharing of data for relapsing polychondritis from worldwide reference centers. Thus, we would be able to evolve toward a better knowledge of its pathophysiology, the publication of new diagnosis criteria, which will include biological markers and imaging findings, the prediction of life-threatening or organ-threatening situations, and the publication of therapeutic evidence-based guidelines after performing at randomized controlled trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.